Renaissance Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,208
Closed -$626K 282
2020
Q3
$626K Sell
2,208
-360
-14% -$100K 0.03% 174
2020
Q2
$687K Buy
2,568
+245
+11% +$73.6K 0.03% 163
2020
Q1
$735K Sell
2,323
-470
-17% -$143K 0.04% 130
2019
Q4
$829K Buy
2,793
+52
+2% +$14.4K 0.03% 149
2019
Q3
$638K Sell
2,741
-83
-3% -$19.3K 0.03% 169
2019
Q2
$660K Sell
2,824
-79,004
-97% -$18.2M 0.03% 166
2019
Q1
$19.3M Sell
81,828
-7,078
-8% -$2.23M 0.77% 56
2018
Q4
$26.8M Sell
88,906
-8,446
-9% -$2.7M 1.23% 20
2018
Q3
$34.4M Sell
97,352
-8,193
-8% -$2.82M 1.2% 17
2018
Q2
$30.6M Sell
105,545
-3,606
-3% -$1.01M 1.09% 26
2018
Q1
$29.9M Sell
109,151
-3,110
-3% -$965K 1.02% 43
2017
Q4
$35.8M Sell
112,261
-6,530
-5% -$2.09M 1.21% 23
2017
Q3
$37.2M Buy
118,791
+4,135
+4% +$1.22M 1.28% 9
2017
Q2
$31.1M Sell
114,656
-1,211
-1% -$320K 1.14% 33
2017
Q1
$31.7M Buy
115,867
+5,811
+5% +$1.64M 1.19% 27
2016
Q4
$31.2M Sell
110,056
-4,269
-4% -$1.27M 1.26% 19
2016
Q3
$35.8M Sell
114,325
-4,063
-3% -$1.2M 1.45% 1
2016
Q2
$28.6M Sell
118,388
-3,461
-3% -$912K 1.2% 32
2016
Q1
$31.7M Buy
121,849
+30,258
+33% +$7.99M 1.28% 19
2015
Q4
$28.1M Buy
91,591
+1,919
+2% +$551K 1.1% 44
2015
Q3
$26.2M Buy
89,672
+3,767
+4% +$1.24M 1.04% 47
2015
Q2
$34.7M Sell
85,905
-1,591
-2% -$639K 1.32% 17
2015
Q1
$36.9M Sell
87,496
-5,180
-6% -$2.04M 1.4% 9
2014
Q4
$31.5M Sell
92,676
-3,905
-4% -$1.26M 1.23% 35
2014
Q3
$31.9M Sell
96,581
-3,123
-3% -$1.03M 1.26% 22
2014
Q2
$31.4M Buy
99,704
+9,429
+10% +$2.84M 1.2% 30
2014
Q1
$27.6M Sell
90,275
-18,824
-17% -$5.98M 1.09% 52
2013
Q4
$30.5M Sell
109,099
-5,547
-5% -$1.43M 1.23% 38
2013
Q3
$27.6M Buy
+114,646
New +$25.7M 1.17% 45

Other funds holding BIIB